Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 4:20 PM
Ignite Modification Date:
2025-12-24 @ 4:20 PM
NCT ID:
NCT00003466
Brief Title:
Temozolomide in Treating Patients With Progressive Low-Grade Glioma
Official Title:
Phase II Treatment of Adults and Children With Progressive Low Grade Gliomas With Temodal
Study:
NCT00003466
Protocol Section:
NCT00003466